July 3, 2026

Vanderbilt Center for Cognitive Medicine seeks participants for trial evaluating Alzheimer’s disease-related psychosis treatment

The ADEPT-4 study evaluates KarXT, an oral medication that may reduce hallucinations and delusions.

By Danny Bonvissuto

March 18, 2026

Vanderbilt Center for Cognitive Medicine enrolls first Down syndrome participant for Alzheimer’s disease study

Evan Dewey and his family travel from Atlanta to participate in the ABATE study, a clinical trial evaluating a treatment that could reduce the likelihood of Alzheimer’s disease development in individuals with Down syndrome

By Danny Bonvissuto

July 19, 2018

Awards bolster investigators’ bipolar disorders research

Two Vanderbilt University researchers have been awarded Blake A. Jenkins Discovery Awards in support of basic and/or translational research into bipolar disorder and related conditions with an emphasis on early detection, intervention and utilizing brain imaging.

By Nancy Humphrey

December 7, 2017

Study seeks to aid diagnosis, management of catatonia

Catatonia, a syndrome of motor, emotional and behavioral abnormalities frequently characterized by muscular rigidity and a trance-like mental stupor and at times manifesting with great excitement or agitation, can occur during a critical illness and appear similar to delirium. But the management strategies are vastly different.

By Nancy Humphrey

February 12, 2015

Hazy definition may hamper catatonia care

Catatonia, a syndrome characterized by muscular rigidity and a trance-like mental stupor, can at times manifest with great excitement and confusion. And while it is often associated with schizophrenia, it can present in patients with either medical or psychiatric conditions. For this reason, the condition has often confused clinicians.

By Nancy Humphrey